1st Quarter - Report

WILLIAMS AND JENSEN, PLLC for GENENTECH INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Intellectual property issues.

LobbyistCovered position, as disclosed
JACK STEVEN HART —
KARINA LYNCH Staff, Sen. Spcl. Cmtee on Aging and Gov. Affrs.
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

H.R. 1, S. 350, ARRA- general tax issues. TARP. Tax extenders.

LobbyistCovered position, as disclosed
DAVID E FRANASIAK —
JACK STEVEN HART —
CHRISTOPHER W HATCHER Sch.C, Treasury and LD, Rep. Scott McInnis

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (111th), S. 350 (111th)

Health Issues HCR

Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life Saving Medicines Act; and Comparative effectiveness legislation including H.R. 1, the American Recovery and Reinvestment Act.

LobbyistCovered position, as disclosed
JACK STEVEN HART —
SUSAN HIRSCHMANN COS, Rep.Van Hilleary & Majority Whip
KARINA LYNCH Staff, Sen. Spcl. Cmtee on Aging and Gov. Affrs.
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 726 (111th), H.R. 1427 (111th), S. 301 (111th), H.R. 1548 (111th), H.R. 1 (111th)

Medicare/Medicaid MMM

Medicare drug benefit, Medicare drug price negotiation, coverage, and payment including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Prescription Drug Gap Reduction Act of 2009.

LobbyistCovered position, as disclosed
JACK STEVEN HART —
KARINA LYNCH Staff, Sen. Spcl. Cmtee on Aging and Gov. Affrs.
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 330 (111th), H.R. 684 (111th), S. 266 (111th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ROCHE HOLDINGS LTD. Switzerland Switzerland 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.